Outset Medical Ownership | Who Owns Outset Medical?
Outset Medical Ownership Summary
Outset Medical is owned by 25.58% institutional investors, 2.71% insiders, and 71.71% retail investors. Fmr is the largest institutional shareholder, holding 15.02% of OM shares. Fidelity Select Health Care is the top mutual fund, with 8.30% of its assets in Outset Medical shares.
OM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Outset Medical | 25.58% | 2.71% | 71.71% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Medical Device Stocks | 37.54% | 10.61% | 51.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 2.66M | 15.02% | $37.63M |
| Pfm health sciences, lp | 1.73M | 9.75% | $24.43M |
| Alyeska investment group | 1.61M | 9.10% | $22.80M |
| Woodline partners lp | 1.33M | 7.47% | $18.72M |
| Blackrock funding, inc. /de | 1.29M | 7.24% | $4.78M |
| Durable capital partners lp | 1.02M | 5.77% | $14.45M |
| Vanguard group | 977.97K | 5.50% | $3.63M |
| Perceptive advisors | 833.33K | 4.70% | $11.77M |
| Ensign peak advisors | 560.17K | 3.14% | $2.08M |
| Bml capital management | 543.18K | 3.05% | $2.02M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pura vida investments | 5.00K | 6.09% | $1.00M |
| Pfm health sciences, lp | 1.73M | 1.88% | $24.43M |
| Bml capital management | 543.18K | 1.74% | $2.02M |
| Parkman healthcare partners | 454.51K | 0.67% | $6.42M |
| Perceptive advisors | 833.33K | 0.34% | $11.77M |
| Catalio capital management, lp | 118.28K | 0.31% | $1.67M |
| Birchview capital, lp | 24.58K | 0.24% | $271.90K |
| Durable capital partners lp | 1.02M | 0.11% | $14.45M |
| Woodline partners lp | 1.33M | 0.09% | $18.72M |
| Alyeska investment group | 1.61M | 0.07% | $22.80M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bml capital management | 543.18K | 1.74% | 543.18K |
| Norges bank | 461.40K | 0.00% | 461.40K |
| Ensign peak advisors | 560.17K | 0.00% | 234.08K |
| Alyeska investment group | 1.61M | 0.07% | 150.00K |
| Balyasny asset management | 143.16K | 0.00% | 143.16K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 880.46K | 0.00% | -2.39M |
| Ameriprise financial | - | - | -1.81M |
| T. rowe price investment management | 2.40K | - | -1.62M |
| Mubadala investment co pjsc | - | - | -1.44M |
| Millennium management | - | - | -1.39M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bml capital management | 543.18K | 1.74% | 543.18K | $2.02M |
| Norges bank | 461.40K | 0.00% | 461.40K | $1.78M |
| Balyasny asset management | 143.16K | 0.00% | 143.16K | $2.75M |
| Stifel financial | 79.92K | 0.00% | 79.92K | $296.52K |
| Aristides capital | 47.70K | 0.03% | 47.70K | $176.97K |
Sold Out
| Holder | Change |
|---|---|
| Missouri trust & investment | -1.00 |
| Northwestern mutual wealth management | -3.00 |
| Td waterhouse canada | -3.00 |
| Ronald blue trust | -4.00 |
| Cranbrook wealth management | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 37 | -61.86% | 4,549,078 | -74.23% | 25 | 0.26% | 20 | -60.00% | 7 | -78.79% |
| Sep 30, 2025 | 38 | -59.14% | 4,157,787 | -77.73% | 23 | 0.21% | 17 | -73.02% | 13 | -13.33% |
| Jun 30, 2025 | 92 | 41.54% | 18,671,271 | 27.00% | 105 | 13.14% | 63 | 215.00% | 14 | -66.67% |
| Mar 31, 2025 | 1 | -98.72% | 24,584 | -99.88% | - | 0.00% | - | -100.00% | 1 | -95.83% |
| Dec 31, 2024 | 31 | -62.20% | 7,241,955 | -72.21% | 14 | 0.54% | 11 | -54.17% | 9 | -74.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Health Care | 1.52M | 8.30% | - |
| Fidelity Advisor Health Care I | 800.00K | 4.37% | - |
| T. Rowe Price US Small-Cap Core Equity | 719.35K | 4.06% | - |
| Vanguard Total Stock Mkt Idx Inv | 552.83K | 3.02% | - |
| MEDICAL BioHealth EUR Acc | 1.54M | 2.95% | 1.54M |
| MFS New Discovery I | 430.59K | 2.42% | - |
| iShares Russell 2000 ETF | 403.63K | 2.20% | 334.23K |
| Fidelity Growth Compy Commingled Pl O | 1.05M | 2.01% | -769.40K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 352.71K | 1.99% | 15.96K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 336.75K | 1.90% | 336.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 17, 2026 | Brottem John L. | General Counsel | Sell | $9.52K |
| Feb 17, 2026 | Trigg Leslie | Chair and CEO | Sell | $11.26K |
| Feb 17, 2026 | Nash Marc | EVP Operations R&D & Service | Sell | $6.09K |
| Jan 20, 2026 | Nash Marc | EVP Operations R&D & Service | Sell | $27.52K |
| Jan 21, 2026 | Nash Marc | EVP Operations R&D & Service | Sell | $4.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 12 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 25 |
OM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools